Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of GCS-100 in Chronic Kidney Disease
NCT02333955Phase 2Withdrawn
- Sponsor
- La Jolla Pharmaceutical Company
- Start
- Jan 2015
- Primary completion
- Jul 2016
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of GCS-100 in chronic kidney disease (CKD), sponsored by La Jolla Pharmaceutical Company. Planned start Jan 2015; status: withdrawn.
02
Drugs
GCS-100
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT02333955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02333955.